IPHA

IPHA

USD

Innate Pharma S.A. ADS

$1.840-0.040 (-2.128%)

Echtzeitkurs

Healthcare
Biotechnologie
Frankreich

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.880

Hoch

$1.880

Tief

$1.840

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

172.7M

Branche

Biotechnologie

Land

France

Handelsstatistiken

Durchschnittliches Volumen

0.02M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $1.29Aktuell $1.840Hoch $3.511

Ähnliche Nachrichten

BusinessWire

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an

Mehr anzeigen
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Analyst Upgrades

HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.

Mehr anzeigen
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target

BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.

Mehr anzeigen
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target